Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 21, 2004, Pages 5435-5439

  Innocenti, Alessio ^a   Lehtonen, Jonna M ^b   Parkkila, Seppo ^b,c   Scozzafava, Andrea ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TAMPERE   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; ARSONIC ACID DERIVATIVE; AZIDE; BENZENEBORONIC ACID; BICARBONATE; BICARBONATE SODIUM COTRANSPORTER; BICARBONATE SODIUM COTRANSPORTER 1; BICARBONATE SODIUM COTRANSPORTER 3; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; CARBONIC ACID; CARBONIC ANHYDRASE XIII; CHLORIDE; CYANIC ACID; CYANIDE; FLUORIDE; HYDROGEN; HYDROGEN SULFIDE; IODIDE; ISOENZYME; METAL COMPLEX; MITOCHONDRIAL ENZYME; MULTIENZYME COMPLEX; NITRATE; NITRITE; SULFANILAMIDE; SULFATE; SULFIDE; THIOCYANATE; UNCLASSIFIED DRUG;

ANION EXCHANGE; ANION TRANSPORT; ARTICLE; BINDING AFFINITY; CYTOSOL; DRUG EFFICACY; DRUG INHIBITION; ENZYME INHIBITION; ENZYME ISOLATION; EVOLUTIONARY ADAPTATION; GENITAL SYSTEM; MITOCHONDRION; PROTEIN ANALYSIS;

ANIMALS; ANIONS; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CYTOSOL; ISOENZYMES; MICE; STRUCTURE-ACTIVITY RELATIONSHIP;

MURINAE;

EID: 5344228703     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.07.086     Document Type: Article

References (31)

1. J. Lehtonen, B. Shen, M. Vihinen, A. Casini, A. Scozzafava, C.T. Supuran, A.K. Parkkila, J. Saarnio, A.J. Kivela, A. Waheed, W.S. Sly, and S. Parkkila J. Biol. Chem. 279 2004 2719 2727
2. A. Scozzafava, A. Mastrolorenzo, and C.T. Supuran Expert Opin. Ther. Pat. 14 2004 667 702
3. C.T. Supuran, A. Scozzafava, and A. Casini Med. Res. Rev. 23 2003 146 189
4. C.T. Supuran, and A. Scozzafava Expert Opin. Ther. Pat. 12 2002 217 242
5. C.T. Supuran, and A. Scozzafava Curr. Med. Chem. Immunol. Endocrinol. Metabol. Agents 1 2001 61 97
6. C.T. Supuran, and A. Scozzafava Expert Opin. Ther. Pat. 10 2000 575 600
7. C.T. Supuran A. Scozzafava J. Conway Carbonic Anhydrase - Its Inhibitors and Activators 2004 CRC Boca Raton (FL), USA 1 363 and references cited therein
8. S. Pastorekova, S. Parkkila, J. Pastorek, and C.T. Supuran J. Enzym. Inhib. Med. Chem. 19 2004 199 229
9. A.K. So, G.S. Espie, E.B. Williams, J.M. Shively, S. Heinhorst, and G.C. Cannon J. Bacteriol. 186 2004 623 630
10. K.S. Smith, and J.G. Ferry FEMS Microbiol. Rev. 24 2000 335 366
11. K.S. Smith, C. Jakubzick, T.S. Whittam, and J.G. Ferry Proc. Natl. Acad Sci. U.S.A. 96 1999 15185 15189
12. J. Lehtonen, S. Parkkila, D. Vullo, A. Casini, A. Scozzafava, and C.T. Supuran Bioorg. Med. Chem. Lett. 14 2004 3757 3762
13. S. Parkkila, K. Kaunisto, S. Kellokumpu, and H. Rajaniemi Histochemistry 95 1991 477 482
14. M. Franchi, D. Vullo, E. Gallori, J. Antel, M. Wurl, A. Scozzafava, and C.T. Supuran Bioorg. Med. Chem. Lett. 13 2003 2857 2861
15. D. Vullo, M. Franchi, E. Gallori, J. Pastorek, A. Scozzafava, S. Pastorekova, and C.T. Supuran J. Enzym. Inhib. Med. Chem. 18 2003 403 406
16. A. Innocenti, S. Zimmerman, J.G. Ferry, A. Scozzafava, and C.T. Supuran Bioorg. Med. Chem. Lett. 14 2004 3327 3331
17. M.A. Ilies, and M.D. Banciu Nonsulfonamide Carbonic Anhydrase Inhibitors C.T. Supuran A. Scozzafava J. Conway Carbonic Anhydrase - Its Inhibitors and Activators 2004 CRC Boca Raton (FL), USA 209 242
18. D. Sterling, R.A. Reithmeier, and J.R. Casey J. Biol. Chem. 276 2001 47886 47894
19. D. Sterling, and J.R. Casey Biochem. Cell Biol. 80 2002 483 497
20. D. Sterling, B.V. Alvarez, and J.R. Casey J. Biol. Chem. 277 2002 25239 25246
21. D. Sterling, N.J.D. Brown, C.T. Supuran, and J.R. Casey Am. J. Physiol. Cell Physiol. 283 2002 C1522 C1529
22. B. Alvarez, F.B. Loiselle, C.T. Supuran, G.J. Schwartz, and J.R. Casey Biochemistry 42 2003 12321 12329
23. 4, 0.5 M NaCl, pH 8.0) and 160 mg lysozyme (Sigma) was added. The resuspended cells were incubated on ice 30 min and lysed by pipetting. Bacterial cell components were removed by centrifugation (13,000 rpm, 15 min, +4°C). The supernatant was directly applied onto Invitrogen's ProBond™- purification system. The ProBond™ purification was performed under native conditions according to Invitrogen's protocol using the ProBond™ resin
24. R.G. Khalifah, D.J. Strader, S.H. Bryant, and S.M. Gibson Biochemistry 16 1977 2241 2247
25. 2 solutions in water at 20°C were used as substrate. Stock solutions of inhibitors were prepared at a concentration of 10-50 mM (in DMSO-water 1:1, v/v) and dilutions up to 0.1 μM done with the assay buffer mentioned above. Inhibitor and enzyme solutions were preincubated together for 10 min at room temperature prior to assay, in order to allow for the formation of the E-I complex. Triplicate experiments were done for each inhibitor concentration, and the values reported throughout the paper are the mean of such results
26. F. Briganti, R. Pierattelli, A. Scozzafava, and C.T. Supuran Eur. J. Med. Chem. 31 1996 1001 1010
27. F. Abbate, C.T. Supuran, A. Scozzafava, P. Orioli, M.T. Stubbs, and G. Klebe J. Med. Chem. 45 2002 3583 3587
28. Zimmerman, S.; Innocenti, A.; Casini, A.; Ferry, J. G.; Scozzafava, A.; Supuran C. T. Bioorg. Med. Chem. Lett., in press
29. H.L. McMurtrie, B.V. Alvarez, F.B. Loiselle, D. Sterling, P.E. Morgan, H.J. Cleary, D.E. Johnson, and J.R. Casey J. Enzym. Inhib. Med. Chem. 19 2004 231 236
30. Sly, W. S.; Waheed, A.; Shah, G.; Zhou, X. Y. Abstract Book, Sixth International Conference on the Carbonic Anhydrases, June 20-25, 2003; Smolenice, Slovakia, p 23
31. C.T. Supuran Expert Opin. Ther. Pat. 13 2003 1545 1550